| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A059QQZ5 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| Q59FP5 | Spectrin, beta, erythrocytic (Includes spherocytosis, clinical type I) variant; Fragment; | NULL | NP_000338.3;NP_001020029.1; | 2332 | human |
| Q9BCS6 | MHC class II antigen; Fragment; | HLA-DRB1; | NULL | 89 | human |
| Q6PK95 | TOP1 protein; Fragment; | TOP1; | NULL | 164 | human |
| Q6PKA6 | ALDH3A1 protein; Fragment; | ALDH3A1; | NP_000682.3; | 512 | human |
| Q6ZNU2 | cDNA FLJ27147 fis, clone SPL09574, highly similar to B-lymphocyte antigen CD19; | NULL | NULL | 363 | human |
| A0A059QPN2 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; | ND3; | NULL | 115 | human |
| Q3C1X0 | Putative uncharacterized protein; | NULL | NULL | 54 | human |
| A5XEI7 | Guanine nucleotide-releasing factor 2; Fragment; | RAPGEF1; | NULL | 126 | human |
| Q5JPJ9 | Putative uncharacterized protein DKFZp686D0114; | DKFZp686D0114; | NULL | 294 | human |
| Q6H2G8 | Natural killer cell inhibitory receptor; Fragment; | KIR2DS2; | NULL | 296 | human |
| Q96AH6 | NARG1L protein; Fragment; | NARG1L; | NULL | 20 | human |
| Q8N352 | NARG1L protein; Fragment; | NARG1L; | NULL | 501 | human |
| A0A059QJR3 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; | ND3; | NULL | 115 | human |
| Q59GH5 | COP9 signalosome subunit 5 variant; Fragment; | NULL | NULL | 276 | human |
| Q96FU4 | Uncharacterized protein; | NULL | NULL | 40 | human |
| Q9HBU4 | Caspase 8 isoform i; Fragment; | NULL | NULL | 12 | human |
| Q4LE58 | EIF4G1 variant protein; Fragment; | EIF4G1; variant; protein; | NULL | 1624 | human |
| Q9UE95 | Leucocyte antigen B; Fragment; | HLA-B; | NULL | 181 | human |
| Q59GL2 | KIAA0367 protein variant; Fragment; | NULL | NULL | 72 | human |
